Children Immunization App (CIMA) among Syrian refugees in Zaatari Camp, Jordan: Protocol for a cluster randomized controlled pilot trial intervention study
Khader, Y.S., Laflamme, L., Schmid, D., El-Halabi, S., Abu Khdair, M., Sengoelge, M., Atkins, S., Tahtamouni, M., Derrough, T., El-Khatib, Z.
Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines
Sturkenboom M, Bahri P, Chiucchiuini A, Grove Krause T, HahnÃ© S, Khromava A, Kokki M, Kramarz P, Kurz X, Larson HJ, de Lusignan S, Mahy P, Torcel-Pagnon L, Titievsky L, Bauchau V; ADVANCE consortium..
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
- Food- and waterborne diseases
- Hepatitis A
- Hepatitis B
- Mass gathering
- Meningococcal disease
- Middle East respiratory syndrome coronavirus
- Public health threat
- Saudi Arabia
- Travellers' health
- Vaccine preventable diseases
- Vector-borne disease
Tetanus - Annual Epidemiological Report for 2017
In 2017, 82 cases of tetanus, including 46 confirmed cases, were reported in the EU/EEA. Adults aged 65 years and above were the most affected age group, with females accounting for the majority of the cases. Cases tended to occur more frequently in the warmer months, which are associated with higher levels of outdoor activity. The current epidemiology of tetanus in the EU/EEA may be explained by lower vaccination coverage or waning immunity in older populations. Due to the severity of tetanus, there is a need to maintain high vaccination rates in all age groups and continue implementing/developing strategies to protect specific groups, particularly the elderly, in countries with higher rates of disease.
Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward
Esposito, S., Principi, N., Rezza, G., Bonanni, P., Gavazzi, G., Beyer, I., Sulzner, M., Celentano, L.P., Prymula, R., Rappagliosi, A., Sevilla, J., Poland, G.